Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury
- PMID: 11031095
- DOI: 10.1006/exnr.2000.7494
Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury
Abstract
We investigated the role of tumor necrosis factor (TNF)-alpha in the onset of neuronal and glial apoptosis after traumatic spinal cord crush injury in rats. A few TUNEL-positive cells were first observed within and surrounding the lesion area 4 h after injury, with the largest number observed 24-48 h after injury. Double-labeling of cells using cell type-specific markers revealed that TUNEL-positive cells were either neurons or oligodendrocytes. One hour after injury, an intense immunoreactivity to TNF-alpha was observed in neurons and glial cells in the lesion area, but also seen in cells several mm from the lesion site rostrally and caudally. The level of nitric oxide (NO) also significantly increased in the spinal cord 4 h after injury. The injection of a neutralizing antibody against TNF-alpha into the lesion site several min after injury significantly reduced both the level of NO observed 4 h thereafter as well as the number of apoptotic cells observed 24 h after spinal cord trauma. An inhibitor of nitric oxide synthase (NOS), N(G)-monomethyl-l-arginine acetate (l-NMMA), also reduced the number of apoptotic cells. This reduction of apoptotic cells was associated with a decrease in DNA laddering on agarose gel electrophoresis. These results suggest that: (i) TNF-alpha may function as an external signal initiating apoptosis in neurons and oligodendrocytes after spinal cord injury; and (ii) TNF-alpha-initiated apoptosis may be mediated in part by NO as produced by a NOS expressed in response to TNF-alpha.
Copyright 2000 Academic Press.
Similar articles
-
Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats.J Neurotrauma. 2003 Feb;20(2):207-19. doi: 10.1089/08977150360547116. J Neurotrauma. 2003. PMID: 12675973
-
Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression.Spine (Phila Pa 1976). 2009 Dec 15;34(26):2848-57. doi: 10.1097/BRS.0b013e3181b0d078. Spine (Phila Pa 1976). 2009. PMID: 19949368
-
Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures.J Neurochem. 2004 Nov;91(3):568-78. doi: 10.1111/j.1471-4159.2004.02780.x. J Neurochem. 2004. PMID: 15485488
-
Traumatic injury of the spinal cord and nitric oxide.Prog Brain Res. 2007;161:171-83. doi: 10.1016/S0079-6123(06)61011-X. Prog Brain Res. 2007. PMID: 17618976 Review.
-
Anti-TNF therapy in the injured spinal cord.Trends Pharmacol Sci. 2011 Feb;32(2):107-15. doi: 10.1016/j.tips.2010.11.009. Epub 2010 Dec 23. Trends Pharmacol Sci. 2011. PMID: 21185611 Review.
Cited by
-
When Pain Hurts: Nociceptive Stimulation Induces a State of Maladaptive Plasticity and Impairs Recovery after Spinal Cord Injury.J Neurotrauma. 2017 May 15;34(10):1873-1890. doi: 10.1089/neu.2016.4626. Epub 2016 Dec 20. J Neurotrauma. 2017. PMID: 27788626 Free PMC article. Review.
-
Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system.J Cell Biol. 2003 Jul 21;162(2):233-43. doi: 10.1083/jcb.200301080. Epub 2003 Jul 14. J Cell Biol. 2003. PMID: 12860969 Free PMC article.
-
Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.J Mol Neurosci. 2003;21(2):173-84. doi: 10.1385/JMN:21:2:173. J Mol Neurosci. 2003. PMID: 14593216
-
Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury.Int J Mol Sci. 2014 Jul 25;15(8):13172-91. doi: 10.3390/ijms150813172. Int J Mol Sci. 2014. PMID: 25068700 Free PMC article. Review.
-
Secretory leukocyte protease inhibitor reverses inhibition by CNS myelin, promotes regeneration in the optic nerve, and suppresses expression of the transforming growth factor-β signaling protein Smad2.J Neurosci. 2013 Mar 20;33(12):5138-51. doi: 10.1523/JNEUROSCI.5321-12.2013. J Neurosci. 2013. PMID: 23516280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical